证券之星消息,截至2026年6月25日收盘,麦科医药-B(02335.HK)报收于39.46港元,上涨6.94%,成交量194.34万股,成交额7426.82万港元。
资金流向数据方面,6月25日麦科医药-B主力资金净流入2005.14万港元,超大单资金净流入2005.14万港元,无大单资金净流入,无中单资金净流入,无小单资金净流入。
投行对该股关注度不高,90天内无投行对其给出评级。
Shaanxi Micot Pharmaceutical Technology Co Ltd, formerly Shaanxi Micot Technology Co Ltd, is a China-based company principally engaged in the research and development of innovative drugs. The Company focuses on the research and development of new drugs for the treatment of cardiovascular and cerebrovascular diseases, metabolic disorders, and inflammatory pain-related diseases. The Company conducts its businesses in the domestic and overseas markets.
以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。
